Vytrus Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Vytrus Biotech has a total shareholder equity of €6.8M and total debt of €2.0M, which brings its debt-to-equity ratio to 29.8%. Its total assets and total liabilities are €10.6M and €3.8M respectively. Vytrus Biotech's EBIT is €632.7K making its interest coverage ratio 5.5. It has cash and short-term investments of €2.2M.
Key information
29.8%
Debt to equity ratio
€2.03m
Debt
| Interest coverage ratio | 5.5x |
| Cash | €2.22m |
| Equity | €6.81m |
| Total liabilities | €3.84m |
| Total assets | €10.64m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: VYT's short term assets (€3.5M) exceed its short term liabilities (€1.1M).
Long Term Liabilities: VYT's short term assets (€3.5M) exceed its long term liabilities (€2.8M).
Debt to Equity History and Analysis
Debt Level: VYT has more cash than its total debt.
Reducing Debt: VYT's debt to equity ratio has reduced from 44.8% to 29.8% over the past 5 years.
Debt Coverage: VYT's debt is well covered by operating cash flow (68.9%).
Interest Coverage: VYT's interest payments on its debt are well covered by EBIT (5.5x coverage).